UTAH MEDICAL PRODUCTS INC 10-K

ITEM 5 - MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market Information. UTMD's common stock trades on the NASDAQ Global Market (stock symbol: UTMD). The following table sets forth the high and low sales price information as reported by NASDAQ for the periods indicated: 2024 2023 High Low High Low 1st Quarter $ 85.76 $ 68.00 $ 101.41 $ 80.75 2nd Quarter 71.55 65.91 100.59 87.54 3rd Quarter 77.33 65.60 99.46 83.63 4th Quarter 68.99 60.39 87.99 75.00 Stockholders. The number of beneficial stockholders of UTMD’s common stock as of March 3, 2025 was at least 2,000. Dividends. The following sets forth cash dividends paid during the past two years: Record Date Payable Date Per Share Amount March 17, 2023 April 4, 2023 0.295 June 16, 2023 July 6, 2023 0.295 September 15, 2023 October 3, 2023 0.295 December 15, 2023 January 3, 2024 0.300 March 15, 2024 April 3, 2024 0.300 June 14, 2024 July 5, 2024 0.300 September 20, 2024 October 4, 2024 0.300 December 16, 2024 January 3, 2025 0.305 2023 total cash dividends paid per share $ 1.1800 2024 total cash dividends paid per share $ 1.2000 Issuer Purchases of Equity Securities. UTMD did not purchase any of its own securities in 2023. In 2024, UTMD purchased 301,961 shares of its common stock for $19,968 including commissions and fees (an average price of $66.13/ share). 2024 Calendar Quarter Shares Repurchased Average Cost Per Share Total Cost [K] 1Q 2024 43,108 $ 69.368 $ 2,990 2Q 2024 95,107 67.326 6,403 3Q 2024 58,377 66.220 3,866 4Q 2024 105,369 63.667 6,709 Year Total 301,961 $ 66.127 $ 19,968 As a subsequent 2025 event, through March 4, 2025 UTMD purchased 36,909 additional shares of its common stock for $2,217 including commissions and fees (an average price of $60.08/ share). ITEM 6 - RESERVED 18